by Marianne de Visser
The EMA is pleased to announce the launch of the new European database of suspected adverse drug reaction reports website at http://www.adrreports.eu/.
The launch of the website is a positive first step in the implementation of the EudraVigilance access policy. The information initially published on the website relates to approximately 650 medicines and active substances authorized through the centralized procedure. Within a year the EMA aims to additionally publish suspected side-effect reports for common drug substances used in nationally-authorized medicines.
Language versions of the website in all 23 community languages are set to go-live by the end of June.
Marianne de Visser is EFNS representative at EMA, Vice President of the EFNS and Professor of Neurology at the Academic Medical Center Amsterdam, The Netherlands
